Patients Rare diseases are not a niche, but Europe’s opportunity to c... Rare diseases are individually uncommon, but collectively affect up to 36 million people in the European Union.
Oncology Personal reflections on World ADC, San Diego At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.
News Nobel Prize in Medicine awarded to optogenetics trio The 2026 Nobel Prize in Physiology or Medicine has been awarded jointly to optogenetics pioneers Karl Deisseroth, Peter Hegemann, and Georg Nagel.
R&D Drug discovery has a human biology problem The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.
R&D Redefining drug discovery: Morocco’s biotech strategy for in... Ongoing work in Morocco demonstrates how developing research infrastructure can support innovative approaches grounded in locally generated data.
News Beren's Niemann-Pick drug Lembaz cleared by FDA The FDA has approved Beren's Lembaz for Niemann-Pick disease type C, the first drug shown to extend survival in the ultra-rare inherited disorder.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.